Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders

Details for Australian Patent Application No. 2002245601 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Carlson, Kenneth E.; Macor, John E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002245601

PCT Pub. Number WO2002/069905

Priority 60/273,291 02.03.01 US; 60/289,719 09.05.01 US; 60/273,206 02.03.01 US

Filing date 4 March 2002

Wipo publication date 19 September 2002

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002245601

24 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245602-GRANULATED ACTIVE INGREDIENTS

2002245600-Purification of red blood cells by separation and diafiltration